Literature DB >> 8190664

Natural history of neuropsychiatric manifestations of HIV disease.

J H Atkinson1, I Grant.   

Abstract

The neuropsychiatric manifestations of HIV disease include neurobiologic and psychobiologic phenomena. The former consist of primary CNS complications caused directly by HIV, and include cognitive disorders (mild neurocognitive disorder and HIV-associated dementia) and other CNS diseases such as myelopathy and the demyelinating neuropathies; and secondary disorders (principally deliria) occasioned by opportunistic infections, neoplasms, cerebrovascular events, and the effects of metabolic derangements and medications. The latter (psychobiologic) phenomena reflect efforts to cope with various nodal, or transition points, in HIV disease; such points of transition include time of serostatus determination, adaptation to asymptomatic seropositivity, response to early medical symptomatology, and later transition to frank AIDS. Anxiety symptoms and various efforts to cope with anxiety (e.g., denial, anger, withdrawal, hypochondriacal preoccupation) all can punctuate these transition points. Additionally, there may be reactivation of long-standing psychopathology (e.g., depression) in seropositive individuals who tend to belong to a group that has an elevated prevalence of pre-infection psychiatric disorder. These interacting neurobiologic and psychobiologic phenomena pose challenges to the psychiatrist who must develop a good understanding of the medical aspects of HIV infection, as well as the neuropsychiatry of AIDS. In this way psychiatric physicians can play an important role in early identification of neuropsychiatric complications, assist the medical team to anticipate emotional and behavioral disturbances, and develop treatment plans that maximize our ability to help those with HIV infection achieve the best possible quality of life.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8190664

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  21 in total

1.  Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Authors:  David J Moore; Kaitlin Blackstone; Steven Paul Woods; Ronald J Ellis; J Hampton Atkinson; Robert K Heaton; Igor Grant
Journal:  AIDS Care       Date:  2012-04-24

2.  Treatment of depression in HIV+men: Literature review and report of an ongoing study of testosterone replacement therapy.

Authors:  J G Rabkin; G Wagner; R Rabkin
Journal:  Ann Behav Med       Date:  1996-03

3.  Stigma, social support, and depression among people living with HIV in Thailand.

Authors:  Li Li; Sung-Jae Lee; Panithee Thammawijaya; Chuleeporn Jiraphongsa; Mary Jane Rotheram-Borus
Journal:  AIDS Care       Date:  2009-08

Review 4.  Affective disorders in patients with HIV infection: impact of antiretroviral therapy.

Authors:  Gabriele Arendt
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 5.  Neuropsychiatric manifestations of HIV infection and AIDS.

Authors:  Benoit Dubé; Tami Benton; Dean G Cruess; Dwight L Evans
Journal:  J Psychiatry Neurosci       Date:  2005-07       Impact factor: 6.186

6.  Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection.

Authors:  Erica Weber; Erin E Morgan; Jennifer E Iudicello; Kaitlin Blackstone; Igor Grant; Ronald J Ellis; Scott L Letendre; Susan Little; Sheldon Morris; Davey M Smith; David J Moore; Steven Paul Woods
Journal:  J Neurovirol       Date:  2012-12-19       Impact factor: 2.643

7.  Participants' perspectives on cognitive-behavioral therapy for adherence and depression in HIV.

Authors:  Carla Berg; Sudha Raminani; Joseph Greer; Meaghan Harwood; Steven Safren
Journal:  Psychother Res       Date:  2008-05

8.  A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals.

Authors:  Steven A Safren; Conall O'Cleirigh; Judy Y Tan; Sudha R Raminani; Laura C Reilly; Michael W Otto; Kenneth H Mayer
Journal:  Health Psychol       Date:  2009-01       Impact factor: 4.267

9.  Neurocognitive impairments in hiv infection.

Authors:  T Edwin; N Nammalvar; S Sabhesan; R Ganesh; H Devarajan
Journal:  Indian J Psychiatry       Date:  1999-01       Impact factor: 1.759

10.  Routine screening for depression: identifying a challenge for successful HIV care.

Authors:  E Shacham; D Nurutdinova; V Satyanarayana; K Stamm; E T Overton
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.